- Home
- KURA vs SGHC Comparison
KURA vs SGHC Comparison
Compare KURA & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- SGHC
- Stock Information
- Founded
- KURA 2014
- SGHC 2020
- Country
- KURA United States
- SGHC Guernsey
- Employees
- KURA N/A
- SGHC N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- SGHC Services-Misc. Amusement & Recreation
- Sector
- KURA Health Care
- SGHC Consumer Discretionary
- Exchange
- KURA Nasdaq
- SGHC Nasdaq
- Market Cap
- KURA 793.2M
- SGHC 3.3B
- IPO Year
- KURA N/A
- SGHC N/A
- Fundamental
- Price
- KURA $7.26
- SGHC $5.67
- Analyst Decision
- KURA Strong Buy
- SGHC Strong Buy
- Analyst Count
- KURA 11
- SGHC 3
- Target Price
- KURA $27.89
- SGHC $8.00
- AVG Volume (30 Days)
- KURA 1.8M
- SGHC 440.5K
- Earning Date
- KURA 02-25-2025
- SGHC 03-05-2025
- Dividend Yield
- KURA N/A
- SGHC 3.55%
- EPS Growth
- KURA N/A
- SGHC N/A
- EPS
- KURA N/A
- SGHC 0.01
- Revenue
- KURA N/A
- SGHC $1,736,303,814.00
- Revenue This Year
- KURA N/A
- SGHC $13.36
- Revenue Next Year
- KURA $233.30
- SGHC $9.46
- P/E Ratio
- KURA N/A
- SGHC $630.20
- Revenue Growth
- KURA N/A
- SGHC 10.78
- 52 Week Low
- KURA $6.98
- SGHC $2.72
- 52 Week High
- KURA $24.17
- SGHC $7.12
- Technical
- Relative Strength Index (RSI)
- KURA 17.38
- SGHC 36.55
- Support Level
- KURA $6.98
- SGHC $5.45
- Resistance Level
- KURA $8.88
- SGHC $6.38
- Average True Range (ATR)
- KURA 0.33
- SGHC 0.17
- MACD
- KURA 0.05
- SGHC -0.11
- Stochastic Oscillator
- KURA 13.40
- SGHC 23.66
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.